Market Trends & Earnings
Hims & Hers Shares Fall After Weight-Loss Strategy Hurts Quarterly Results
By Intent.Health Team • May 12, 2026
What’s happening
Hims & Hers Health shares dropped sharply after the company’s aggressive focus on weight-loss treatments hurt quarterly performance.
What’s changing / Business impact
- Heavy dependence on: obesity drug demand and GLP-1-related business growth.
- Investors becoming cautious about: sustainability of telehealth obesity strategies.
Why this matters
Many healthcare startups are rapidly pivoting toward obesity drugs because demand is exploding.
This shows:
- The obesity market is huge, but also risky and competitive.
- Companies can become overly dependent on one healthcare trend.